BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 20580243)

  • 1. Integrin-linked kinase, phosphorylated AKT and the prognosis of malignant pleural mesothelioma.
    Watzka SB; Setinek U; Stubenberger EB; Tötsch M; Dekan G; Marcher M; Fleck T; Müller MR
    Eur J Cardiothorac Surg; 2011 Feb; 39(2):180-4. PubMed ID: 20580243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactivity of integrin-linked kinase in human mesothelial cell proliferation.
    Watzka SB; Setinek U; Huber M; Cantonati H; Lax F; Watson S; Weigel G; Müller MR
    Interact Cardiovasc Thorac Surg; 2008 Feb; 7(1):107-10. PubMed ID: 18048409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of integrin-linked kinase in the serum of patients with malignant pleural mesothelioma.
    Watzka SB; Posch F; Pass HI; Huflejt M; Bernhard D; Hannigan GE; Müller MR
    J Thorac Cardiovasc Surg; 2011 Aug; 142(2):384-9. PubMed ID: 21620418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombospondin-1 expression and clinical implications in malignant pleural mesothelioma.
    Ohta Y; Shridhar V; Kalemkerian GP; Bright RK; Watanabe Y; Pass HI
    Cancer; 1999 Jun; 85(12):2570-6. PubMed ID: 10375104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic and molecular significance of phospho-Akt expression in early invasive breast cancer.
    Aleskandarany MA; Rakha EA; Ahmed MA; Powe DG; Ellis IO; Green AR
    Breast Cancer Res Treat; 2011 Jun; 127(2):407-16. PubMed ID: 20617378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patients.
    Borasio P; Berruti A; Billé A; Lausi P; Levra MG; Giardino R; Ardissone F
    Eur J Cardiothorac Surg; 2008 Feb; 33(2):307-13. PubMed ID: 18164622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymidylate synthase but not excision repair cross-complementation group 1 tumor expression predicts outcome in patients with malignant pleural mesothelioma treated with pemetrexed-based chemotherapy.
    Righi L; Papotti MG; Ceppi P; Billè A; Bacillo E; Molinaro L; Ruffini E; Scagliotti GV; Selvaggi G
    J Clin Oncol; 2010 Mar; 28(9):1534-9. PubMed ID: 20177021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of osteopontin and serum mesothelin in malignant pleural mesothelioma diagnosis and prognosis assessment.
    Grigoriu BD; Scherpereel A; Devos P; Chahine B; Letourneux M; Lebailly P; Grégoire M; Porte H; Copin MC; Lassalle P
    Clin Cancer Res; 2007 May; 13(10):2928-35. PubMed ID: 17504993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating endothelial cell (CEC) as a diagnostic and prognostic marker in malignant pleural mesothelioma (MPM).
    Yoneda K; Tanaka F; Kondo N; Orui H; Hashimoto M; Takuwa T; Matsumoto S; Okumura Y; Tsubota N; Sato A; Tsujimura T; Kuribayashi K; Fukuoka K; Nakano T; Hasegawa S
    Ann Surg Oncol; 2012 Dec; 19(13):4229-37. PubMed ID: 22825770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylated Akt expression is a prognostic marker in early-stage non-small cell lung cancer.
    Yip PY; Cooper WA; Kohonen-Corish MR; Lin BP; McCaughan BC; Boyer MJ; Kench JG; Horvath LG
    J Clin Pathol; 2014 Apr; 67(4):333-40. PubMed ID: 24265323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic role of osteopontin expression in malignant pleural mesothelioma.
    Cappia S; Righi L; Mirabelli D; Ceppi P; Bacillo E; Ardissone F; Molinaro L; Scagliotti GV; Papotti M
    Am J Clin Pathol; 2008 Jul; 130(1):58-64. PubMed ID: 18550471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of Bax and Fas ligand in erionite and asbestos induced Turkish malignant pleural mesothelioma.
    Kokturk N; Firat P; Akay H; Kadilar C; Ozturk C; Zorlu F; Gungen Y; Emri S
    Lung Cancer; 2005 Nov; 50(2):189-98. PubMed ID: 16043260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble mesothelin-related peptide level elevation in mesothelioma serum and pleural effusions.
    Pass HI; Wali A; Tang N; Ivanova A; Ivanov S; Harbut M; Carbone M; Allard J
    Ann Thorac Surg; 2008 Jan; 85(1):265-72; discussion 272. PubMed ID: 18154821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term prognostic analysis of patients with malignant pleural mesothelioma].
    Cao KJ; Cui NJ
    Ai Zheng; 2005 Jan; 24(1):72-5. PubMed ID: 15642204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploratory analysis of activation of PTEN-PI3K pathway and downstream proteins in malignant pleural mesothelioma (MPM).
    Cedrés S; Montero MA; Martinez P; Martinez A; Rodríguez-Freixinós V; Torrejon D; Gabaldon A; Salcedo M; Ramon Y Cajal S; Felip E
    Lung Cancer; 2012 Jul; 77(1):192-8. PubMed ID: 22459204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of epithelial-mesenchymal transition in malignant pleural mesothelioma.
    Schramm A; Opitz I; Thies S; Seifert B; Moch H; Weder W; Soltermann A
    Eur J Cardiothorac Surg; 2010 Mar; 37(3):566-72. PubMed ID: 19781955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An immunohistochemical evaluation of phosphorylated Akt at threonine 308 [pAkt(Thr308)] in invasive breast cancer.
    Magkou C; Mylona E; Theohari I; Giannopoulou I; Papanikolaou E; Markaki S; Nakopoulou L
    In Vivo; 2007; 21(6):967-72. PubMed ID: 18210742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer.
    Mudduluru G; Medved F; Grobholz R; Jost C; Gruber A; Leupold JH; Post S; Jansen A; Colburn NH; Allgayer H
    Cancer; 2007 Oct; 110(8):1697-707. PubMed ID: 17849461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spatial relationship of phosphorylated epidermal growth factor receptor and activated AKT in head and neck squamous cell carcinoma.
    Nijkamp MM; Hoogsteen IJ; Span PN; Takes RP; Lok J; Rijken PF; van der Kogel AJ; Bussink J; Kaanders JH
    Radiother Oncol; 2011 Oct; 101(1):165-70. PubMed ID: 21775008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. May cyclooxygenase-2 (COX-2), p21 and p27 expression affect prognosis and therapeutic strategy of patients with malignant pleural mesothelioma?
    Mineo TC; Ambrogi V; Cufari ME; Pompeo E
    Eur J Cardiothorac Surg; 2010 Sep; 38(3):245-52. PubMed ID: 20338775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.